AzTrials
AzTrials

Crossbite (Posterior)RCT expansionNCT07533682

Comparison of Maxillary Dental Expansion Using Smartee Clear Aligner With and Without S11 Expander: A Randomized Clinical Trial

A study testing maxillary expander with transpalatal strap S11 and conventional expantion in people with Crossbite (Posterior) and Expansion of Maxillary Arch, run by Aisha Ali Qahtani at 1 site in Saudi Arabia.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

To compare the effects of Smartee S11 expander with conventional clear aligner expansion using cone beam computed tomography (CBCT). The secondary objective is to evaluate the degree of orthodontic expansion and the type of tooth movement achieved with Smartee aligners on the maxillary arch. Read more about this study

Who is it for?
Ages 18 to 35 years
What is being tested?
maxillary expander with transpalatal strap S11 and conventional expantion
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteSaudi Arabia
Study dates
14 May 2026to 20 May 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 35 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • 1- healthy cooperative female and male patients who will undergo maxillary expansion with Smartee aligners, A young adult/adult patients starting from age of 18 up to 35 years old.
  • 2- patients with maxillary compression of non-skeletal origin, moderate dental crowding in the upper arch (4-8mm). 3- patients with unilateral or bilateral crossbite, patients will be treated with intermaxillary elastics without distalization or mesialization of the dental arches.
  • 4- patients with sufficient clinical crown height (greater than 4 mm), no mesial rotation of the upper first molar. 5- there is good compliance during the treatment (wearing aligners for 20 hours per day).
  • 6- good quality x-rays with appropriate visualization of landmarks and control of head rotation. 7- absence of periodontal disease, and absence of previous prosthodontic treatments of the upper molars.

Who cannot join

  • 1- signs and/or symptoms of temporomandibular abnormalities (TMDs). 2- active periodontal disease. 3- prosthodontic rehabilitations of the maxillary molar or ankylosed teeth, and endodontic treatments of the maxillary molars. 4- patients requiring orthognathic surgery

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

aisha ali qahtani, postgraduate contact

00966554886261

seenmeem44@gmail.com

Saudi Arabia1 site
  • Private Clinic

    Jeddah

Other trials in Saudi Arabia

About this study

To compare the effects of Smartee S11 expander with conventional clear aligner expansion using cone beam computed tomography (CBCT).

The secondary objective is to evaluate the degree of orthodontic expansion and the type of tooth movement achieved with Smartee aligners on the maxillary arch.

Read the detailed description

Each patient will be randomly allocated, and the entire patient included in this study will be divided into two groups.

Being tested
maxillary expander with transpalatal strap S11, conventional expantion
Medical subject headings
Malocclusion

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • maxillary expander with transpalatal strap S11Device

    new feature incorporated into the aligners, called trans Palatal bar (S11-Horizontal Arch Expander) which is an invisible clear trans Palatal expander customized to the patient through digital design and individual cutting

  • conventional expantionDevice

    maxillary expansion with conventional expansion design

Study groups in NCT07533682
Study groupRoleWhat they receive
group 1Active comparatorwith conventional expander
Receives: Device: conventional expantion
group 2Experimentalwith S11 expander
Receives: Device: maxillary expander with transpalatal strap S11

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. comparison the effect of S11 expander with conventional one

    To compare the effects of Smartee S11 expander with conventional clear aligner expansion using cone beam computed tomography (CBCT).

    Measured: from the enrollment to the end of expansion at 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Apr 2026
  2. Study start14 May 2026 (estimated)
  3. Primary completion20 Dec 2026 (estimated)
  4. Study completion20 May 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Each patient will be randomly allocated, and the entire patient included in this study will be divided into two groups. One group will be treated using the Smartee aligner expander, and the other group will be treated using the conventional clear aligner expansion. For each patient, the Smartee check will be provided by the same operator using the same standardized expansion protocol, and expansion of the arch will be limited between the first molar up to the canine, excluding the second molar. Moreover, each patient will be instructed to wear their aligners full-time, only removing them for meals and oral hygiene, and to change them every 7 days.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07533682
Sponsor's protocol ID
133-10-25
Other IDs
no ID
Acronym
RCT expansion
Status last verified
Apr 2026
First submitted
10 Apr 2026
Last updated
16 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: The dataset contains sensitive patient information, and sharing it could compromise participant confidentiality despite de-identification efforts. Access to the data is therefore restricted in accordance with institutional review board (IRB) guidelines.

Questions about this trial

What is this clinical trial studying?

A study testing maxillary expander with transpalatal strap S11 and conventional expantion in people with Crossbite (Posterior) and Expansion of Maxillary Arch, run by Aisha Ali Qahtani at 1 site in Saudi Arabia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 16 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Saudi Arabia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact aisha ali qahtani, postgraduate (00966554886261, seenmeem44@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

comparison the effect of S11 expander with conventional one (time frame: from the enrollment to the end of expansion at 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in